• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Immunocore Holdings Plc ADR (NQ: IMCR )

    34.02 -0.65 (-1.87%)
    Streaming Delayed Price Updated: 10:29 AM EDT, Sep 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Immunocore Holdings Plc ADR

    < Previous 1 2 3 4 5 Next >
    Immunocore to present at upcoming investor conferences
    From Immunocore Holdings Limited
    Via GlobeNewswire
    Expert Ratings for Immunocore Hldgs
    Via Benzinga
    Recap: Immunocore Hldgs Q1 Earnings
    Via Benzinga
    Immunocore Reports First Quarter 2023 Financial Results and Provides Business Update
    From Immunocore Holdings Limited
    Via GlobeNewswire
    Immunocore to present at the Bank of America Securities 2023 Health Care Conference
    From Immunocore Holdings Limited
    Via GlobeNewswire
    Analyst Ratings for Immunocore Hldgs
    Via Benzinga
    Earnings Scheduled For March 1, 2023
    Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million. 
    Via Benzinga
    Preview: Immunocore Holdings's Earnings
    Via Benzinga
    Immunocore Reveals First Data From HIV Infection Candidate Study
    Via Benzinga
    Immunocore presents new KIMMTRAK data confirming association between early ctDNA reduction and longer overall survival
    From Immunocore Holdings Limited
    Via GlobeNewswire
    Short Volatility Alert: Immunocore Hldgs
    On Friday, shares of Immunocore Hldgs (NASDAQ: IMCR) experienced volatile short activity. After the activity, the stock price went up +3.38% to $54.81. The overall sentiment for IMCR has been Bearish. 
    Via Benzinga
    Immunocore to present at the 22nd Annual Needham Virtual Healthcare Conference
    From Immunocore Holdings Limited
    Via GlobeNewswire
    Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2023
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2023
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Immunocore to present four posters at AACR Annual Meeting 2023
    From Immunocore Holdings Limited
    Via GlobeNewswire
    Immunocore Reports 2022 Financial Results and Provides Business Update
    From Immunocore Holdings Limited
    Via GlobeNewswire
    Immunocore to present at upcoming investor conferences
    From Immunocore Holdings Limited
    Via GlobeNewswire
    Immunocore to Report Fourth Quarter and Full Year 2022 Earnings and Host Call on March 1, 2023
    From Immunocore Holdings Limited
    Via GlobeNewswire
    Immunocore announces initial Phase 1 safety and pharmacodynamic activity data with first soluble TCR therapy for people living with HIV
    From Immunocore Holdings Limited
    Via GlobeNewswire
    Biotech's Drug Pipeline Expands From Melanoma To Other Cancers
    Immunocore is the IBD Stock of the Day as the biotech company expands its pipeline. Earnings For IMCR stock are due in March. 
    Via Investor's Business Daily
    Is Biotech Immunocore About To Make A 25% Price Move?
    Small-cap Immunocore has been a price leader within the biotech industry. Analysts have a "buy" rating on the stock and estimate that it will move 25% higher. 
    Via MarketBeat
    Topics ETFs
    Immunocore to present at upcoming investor conferences
    From Immunocore Holdings Limited
    Via GlobeNewswire
    3 Pharma Stocks That Will Mint Millionaires
    These pharma stocks all have excellent risk-reward ratios and the companies have developed treatments that could easily become blockbusters. 
    Via InvestorPlace
    Immunocore announces strategic priorities including pipeline expansion for 2023 -2024
    From Immunocore Holdings Limited
    Via GlobeNewswire
    Immunocore to present at the 41st Annual J.P. Morgan Healthcare Conference
    From Immunocore Holdings Limited
    Via GlobeNewswire
    Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2022
    Via Benzinga
    Immunocore is awarded the Prix Galien France award for KIMMTRAK
    From Immunocore Holdings Limited
    Via GlobeNewswire
    Immunocore presents ovarian cancer expansion data for ImmTAC® candidate IMC-C103C targeting MAGE-A4
    From Immunocore Holdings Limited
    Via GlobeNewswire
    Immunocore and Gadeta Announce Agreement to Develop First Gamma Delta (γδ) TCR ImmTAC for Solid Tumors
    From Immunocore Holdings Limited
    Via GlobeNewswire
    < Previous 1 2 3 4 5 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.